AFFLUENT MEDICAL overview

Affluent Medical Affluent Medical announces several key appointments for Medical and Clinical affairs. 11-March-2025 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical announces several key appointments for Medical and Clinical affairs. Appointment of Dr. Howard C. Herrmann as strategic Chief Medical Officer for structural heart platform. Appointment of Pr....

EQS-News: Affluent Medical SA / Key word(s): Miscellaneous Affluent Medical announces several key appointments for Medical and Clinical affairs. 11.03.2025 / 17:45 CET/CEST The issuer is solely responsible for the content of this announcement. Affluent Medical announces several key appointments for Medical and Clinical affairs. Appointment of Dr. Howard C. Herrmann as strategic Chief Medical Officer for structural heart platform. Appointment of Pr. Nicolas Barry Delongchamps as strategic Chief...

Affluent Medical Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors. 25-Feb-2025 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors Aix-en-Provence, February 25, 2025 –...

EQS-News: Affluent Medical SA / Key word(s): Personnel Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors 25.02.2025 / 17:45 CET/CEST The issuer is solely responsible for the content of this announcement. Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors Aix-en-Provence, February 25, 2025 – 5:45 p.m. CET – Affluent Medical...

EQS-News: Affluent Medical SA / Key word(s): Study Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase 30.01.2025 / 17:45 CET/CEST The issuer is solely responsible for the content of this announcement. Affluent Medical announces 10 th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase Completion of the pilot phase of the European multicenter clinical study in humans...

Affluent Medical Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase. 30-Jan-2025 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Affluent Medical announces 10 th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase Completion of the pilot phase of the European...

EQS-News: Affluent Medical SA / Key word(s): Conference Affluent Medical Announces Participation in Upcoming Scientific Events 08.10.2024 / 17:45 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical Announces Participation in Upcoming Scientific Events Aix-en-Provence, October 8, 2024 – 5:45 p.m. CEST – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME – "Affluent"), a French clinical-stage medical technology company...

Affluent Medical Affluent Medical Announces Participation in Upcoming Scientific Events. 08-Oct-2024 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical Announces Participation in Upcoming Scientific Events Aix-en-Provence, October 8, 2024 – 5:45 p.m. CEST – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME – "Affluent"), a French clinical-stage...